ConductScience.org, home

Paper42137125

Analysis of complete and incomplete response to neoadjuvant therapy in rectum cancer patients.

TajikRostami F and 5 others. Gastroenterol Hepatol Bed Bench, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Analysis of complete and incomplete response to neoadjuvant therapy in rectum cancer patients. Papers, record 42137125. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42137125

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Analysis of complete and incomplete response to neoadjuvant therapy in rectum cancer patients.
PubMed
Journal
Gastroenterol Hepatol Bed Bench
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1TajikRostami FFatemeh
2Tavirani MRMajid Rezaei
3Ataei EElnaz
4Rezaei-Tavirani MMostafa
5Mohaghegh-Shalmani HHamid
6Norouzinia MMohsen

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111279603Amyloid beta protein precursor is involved in the growth of human colon carcinoma cell in vitro and in vivo.Int J Cancer2001https://conductscience.org/library/papers/11279603PubMed
239003454Key genes and molecular mechanisms related to Paclitaxel Resistance.Cancer Cell Int2024https://conductscience.org/library/papers/39003454PubMed
338433568Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: A mechanistic insight.Phytother Res2024https://conductscience.org/library/papers/38433568PubMed
423634254CDK4: A Key Player in the Cell Cycle, Development, and Cancer.Genes Cancer2012https://conductscience.org/library/papers/23634254PubMed
515142631Review of epidermal growth factor receptor biology.Int J Radiat Oncol Biol Phys2004https://conductscience.org/library/papers/15142631PubMed
620140529Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.Ann Surg Oncol2010https://conductscience.org/library/papers/20140529PubMed
739757310Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer.Mol Biomed2025https://conductscience.org/library/papers/39757310PubMed
826328044Protein-Protein Interaction Network could reveal the relationship between the breast and colon cancer.Gastroenterol Hepatol Bed Bench2015https://conductscience.org/library/papers/26328044PubMed
937793085
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors.
J Clin Oncol2024https://conductscience.org/library/papers/37793085PubMed
1034208601Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer.Int J Mol Sci2021https://conductscience.org/library/papers/34208601PubMed
1137527040FRMD8 targets both CDK4 activation and RB degradation to suppress colon cancer growth.Cell Rep2023https://conductscience.org/library/papers/37527040PubMed
1210874008Expression of Jun family members in human colorectal adenocarcinoma.Carcinogenesis2000https://conductscience.org/library/papers/10874008PubMed
1339000238Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance.Int J Mol Sci2024https://conductscience.org/library/papers/39000238PubMed
1431191840Gene screening of colorectal cancers via network analysis.Gastroenterol Hepatol Bed Bench2019https://conductscience.org/library/papers/31191840PubMed
1529045232Imaging Neoadjuvant Therapy Response in Breast Cancer.Radiology2017https://conductscience.org/library/papers/29045232PubMed
1623331916The origins of multicellular organisms.Evol Dev2013https://conductscience.org/library/papers/23331916PubMed
1738918650Diagnostic and Prognostic Value of miR-451 Expression in Colorectal Cancer: A Meta-Analysis.Asian Pac J Cancer Prev2024https://conductscience.org/library/papers/38918650PubMed
1836879254Identification of hub genes and potential molecular mechanisms related to radiotherapy sensitivity in rectal cancer based on multiple datasets.J Transl Med2023https://conductscience.org/library/papers/36879254PubMed
1935197754Linsitinib and aspirin as the IGF1-R antagonists, inhibit regorafenib-resistant chemotherapy in colon cancer.Saudi J Biol Sci2022https://conductscience.org/library/papers/35197754PubMed
2035970919Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer.Nat Med2022https://conductscience.org/library/papers/35970919PubMed

See all 25 referencesDownload CSV of references

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
CDK41019PubTator's text mininghttps://conductscience.org/library/genes/1019NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
GNRH12796PubTator's text mininghttps://conductscience.org/library/genes/2796NCBI Gene
IGF13479PubTator's text mininghttps://conductscience.org/library/genes/3479NCBI Gene
JUN3725PubTator's text mininghttps://conductscience.org/library/genes/3725NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42137125

GET https://conductscience.org/api/papers/v1/42137125/references?page=2